Westborough, Mass. — Miach Orthopaedics, Inc. said it will present two-year outcomes from the first 200 patients enrolled in the Bridge Registry at the American Orthopaedic Society for Sports Medicine Annual Meeting, taking place July 8-11 in Seattle.
The company, which developed the Bridge-Enhanced ACL Restoration, or BEAR Implant, said the presentation will highlight how updated fixation and suture techniques have further advanced the BEAR Implant procedure for anterior cruciate ligament tears.
Miach said two-year outcomes for the 200-patient group are trending with results from the first 100 patients recently published in the Video Journal of Sports Medicine, which showed a 5% ACL retear rate.
“One of the most encouraging findings from the Bridge Registry is that refinements in BEAR Implant surgical technique can have a meaningful impact on patient outcomes,” said Dr. Jocelyn Wittstein, orthopedic surgeon at Duke University and co-investigator of the Bridge Registry study. “The modified techniques were associated with a lower overall reoperation rate than the original technique, with no difference in other safety outcomes, giving surgeons’ greater confidence as they incorporate the BEAR Implant into their clinical practice.”
At AOSSM, Miach Orthopaedics said it will highlight the techniques and additional findings, along with the growing body of evidence supporting ACL restoration.
The company’s activities include “Playing the ACL Long Game: Registry Outcomes and Reduction of Post-Traumatic Osteoarthritis with the BEAR Implant,” featuring Dr. Jay Albright, Dr. Jacqueline Brady and Wittstein; “The BEAR Implant Experience: Restoring ACLs the Natural Way,” featuring Dr. Brian Lau; and “ACL Preservation Evolved: Clinical Experience & Advanced Techniques with the BEAR Implant,” featuring Dr. Gregory DiFelice, a Miach strategic advisor.
“Nearly 10,000 patients have now been treated with the BEAR Implant, and the evidence continues to demonstrate what’s possible when surgeons preserve the native ACL,” said Jamal Rushdy, president and chief executive officer of Miach Orthopaedics. “We are committed to advancing ACL restoration through continued innovation in surgical technique and a growing understanding of the importance of long-term knee health so more surgeons can confidently make ACL restoration an integral part of their treatment algorithm.”
